Traffic is tracked using AWstats. RCSB.org is visited by >1 million unique visitors/year.
|April 2019||762,930||2,695,239||10549.01 GB|
|May 2019||685,154||2,296,252||8803.14 GB|
|June 2019||509,592||1,594,699||7380.16 GB|
RCSB PDB is looking for a Front End Developer to join the Development Team at Rutgers, The State University of New Jersey.
Develop state-of-the-art features and search/reporting tools for RCSB.org that will support a broad spectrum of users from high school students to professional scientists.
Discovery and development of 210 new molecular entities approved by the US Food and Drug Administration from 2010–2016 was facilitated by 3D structural information generated by structural biologists worldwide and distributed on an open-access basis by the PDB. Nearly 6,000 PDB structures containing one of the known targets and/or a new drug are available; more than half were published and made available in the PDB archive more than 10 years before drug approval.
For the full analysis, see How Structural Biologists and the Protein Data Bank Contributed to Recent FDA New Drug Approvals in Structure ((2019) 27: 211-217 doi: 10.1016/j.str.2018.11.007).
BioJava 5: A community driven open-source bioinformatics library (2019) PLoS Comput Biol 15: e1006791. doi: 10.1371/journal.pcbi.1006791
Analyzing the symmetrical arrangement of structural repeats in proteins with CE-Symm (2019) PLoS Comput Biol 15: e1006842 doi: 10.1371/journal.pcbi.1006842